Company intelligence / Profile preview

Appsolute

Ownership: Private
Development stage: Other

Overview

Absolute Biotech is a global manufacturer and supplier specializing in antibody reagents, kits, sequencing, engineering, validation services, and recombinant antibody manufacturing. The company’s offerings are designed to support annotation, validation, sequencing, engineering, and recombinant production of antibodies for life science tools development as well as translational/preclinical biotherapeutic programs. In June 2024 it merged with Vector Laboratories to expand its capabilities in bioconjugation linkers/protein detection solutions for pharma/biopharma customers.

Therapeutic areas: Other
Modalities: AntibodyRecombinant proteinKit (for research use)
Industry: Chemicals & Materials

Partnerships

Vector Laboratories (merged partner)Thompson Street Capital Partners (ownership/strategic partnership)Pharma/biopharma clients globally (as customers)

Beyond the preview

Go deeper on Appsolute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Appsolute.

Explore the full profile